Latest news
Veracyte: Core Growth Funds Prosigna And TrueMRD (NASDAQ:VCYT) - Seeking AlphaSeeking Alpha · Mon, 10 Aug 2026 03:30:12 GMTAdaptive Biotechnologies (ADPT) Is Up 10.5% After Raising 2026 MRD Revenue Guidance Has The Bull Case Changed? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 15:35:48 GMTAdaptive Biotechnologies Corp (1HM) Q1 2026 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Fri, 07 Aug 2026 14:17:29 GMTNatera Q2 Earnings Call Highlights - TradingViewTradingView · Fri, 07 Aug 2026 06:04:00 GMTREFR: Record test volumes and revenue growth drive raised 2026 outlook and margin expansion - TradingViewTradingView · Thu, 06 Aug 2026 21:57:51 GMTWeekly Recap: Q2 revenue and MRD growth and Morgan Stanley target hike - TradingViewTradingView · Mon, 03 Aug 2026 11:33:04 GMTAdaptive Biotechnologies (ADPT) Raised MRD Guidance, Is The Stock Fairly Valued? - SahmSahm · Sun, 02 Aug 2026 07:00:00 GMTTEM: Q2 2026 delivered 22% revenue growth, net income turnaround, and major MRD expansion via acquisition - TradingViewTradingView · Thu, 30 Jul 2026 20:07:51 GMT